Gilead Sciences

Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed …

Gilead Sciences received approval from the U.S. Food and Drug Association to begin trials of an easier …

Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus …

Egypt-based Eva Pharma has signed a deal with Gilead Sciences for manufacturing and sale of remdesivir, which …

Gilead Sciences’ antiviral drug remdesivir has helped to prevent macaques infected with the coronavirus from developing respiratory …

Gilead Sciences Inc said that its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in …

Gilead Sciences has signed a licencing agreement with five generic drugmakers to make antiviral drug remdesivir in …

The World Health Organisation (WHO) is planning to speak with the U.S. government and biotech firm Gilead …

Gilead Sciences is doing its best to make experimental antiviral drug remdesivir accessible and affordable to coronavirus …

Gilead Sciences said on Thursday that it can produce “several million” rounds of its antiviral drug remdesivir in …